144 studies found for:
Emtricitabina/ Fumarato de disoproxilo de tenofovir OR Truvada[TREATMENT] AND HIV [CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Unknown † |
Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
|
||||
| 22 | Recruiting |
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
|
||||
| 23 | Unknown † |
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
|
||||
| 24 | Not yet recruiting |
A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
|
||||
| 25 |
Completed
Has Results |
Safety and Efficacy Study of Switching From Epzicom to Truvada
|
||||
| 26 | Withdrawn |
A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
|
||||
| 27 | Unknown † |
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
|
||||
| 28 | Unknown † |
The First Failure Study
|
||||
| 29 | Recruiting |
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
|
||||
| 30 | Recruiting |
Atripla to Raltegravir Switch Study
|
||||
| 31 | Completed |
Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM5)(COMPLETED)
|
||||
| 32 | Not yet recruiting |
SCOPE: Strategies to Combine PrEP With Prevention Efforts
|
||||
| 33 | Recruiting |
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
|
||||
| 34 | Not yet recruiting |
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
|
||||
| 35 | Active, not recruiting |
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
|
||||
| 36 |
Completed
Has Results |
Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada
|
||||
| 37 | Completed |
Raltegravir as Early Therapy in African-Americans Living With HIV Study
|
||||
| 38 | Completed |
SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada
|
||||
| 39 | Completed |
SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
|
||||
| 40 | Recruiting |
Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
|
† Indicates status has not been verified in more than two years

